Publications
Publications
Show Results For
-
All HBS Web
(115,724)
- Faculty Publications (258)
Page 1 of
258
Results
→
- (Revised May 2024)
- Teaching Note
Lyric Dinner Theater (A) and (B)
By: Richard G. Hamermesh, Jim Sharpe and Noah Fisher
This teaching note is associated with HBS cases 813-043 and 813-044.
View Details
- January 17, 2022
- Article
Reducing Racial Disparities in Cancer Outcomes
By: Kathy Giusti and Richard G. Hamermesh
A disproportionate number of Black patients die from cancer in the United States. A key to addressing this problem is enrolling more Black patients in clinical trials. A strategy consisting of these three parts can help accomplish this goal: 1) centralize information...
View Details
- June 11, 2021
- Article
Addressing Demographic Disparities in Clinical Trials
By: Kathy Giusti, Richard G. Hamermesh and Mark Krasnow
Disparities in health care are not just limited to the delivery of care. They also exist in the way that clinical trials are structured. Women, people of color, and the elderly often are not adequately represented. This article offers three strategies for addressing...
View Details
- September 30, 2020
- Article
How Nonprofit Foundations Can Sustainably Fund Disease Research
By: Richard G. Hamermesh and Kathy Giusti
- August 18, 2020
- Article
What It Takes to Lead a Disease Research Foundation
By: Richard G. Hamermesh and Kathy Giusti
- June 2020
- Case
Breakthroughs at Blueprint Medicines
By: Richard G. Hamermesh, Kathy Giusti and Susie L. Ma
Precision medicine company Blueprint Medicines was building a successful track record for bringing drug therapies to market 40% faster than average. The company had spent $40 million dollars and two years building a compound library that became its drug development...
View Details
- March 6, 2020
- Article
How Medical Nonprofits Set Winning Strategy
By: Kathy Giusti and Richard G. Hamermesh
- Article
How Harvard Business School Is Advancing Precision Medicine
By: Kathy Giusti and Richard G. Hamermesh
- September 2019
- Case
Dementia Discovery Fund
By: Richard G. Hamermesh, Kathy Giusti and Sarah Gulick
The case is set in March 2019, and tells the story of the founding of the Dementia Discovery Fund (DDF). The idea for the fund began in 2015, when then-Prime Minister David Cameron spoke about the importance of making breakthroughs in dementia research, and pledged...
View Details
- July 2019 (Revised July 2019)
- Teaching Note
Intermountain Healthcare: Pursuing Precision Medicine
By: Richard G. Hamermesh, Robert S. Huckman and Julia Kelley
- June 4, 2019
- Article
Finding the Sweet Spot: Why Industry, Nonprofits Should (or Can) Collaborate on Master Protocols
By: Richard G. Hamermesh, Kathy Giusti and Bradley Smith
- 28 Feb 2019
- Interview
Pursuing Precision Medicine at Intermountain Healthcare
By: Richard G. Hamermesh and Brian Kenny
- February 25, 2019
- Article
Impact Investing: A New Way to Fund Cures for Cancer
By: Richard G. Hamermesh and Kathy Giusti
- December 12, 2018
- Article
Impact Investing Could Accelerate the Fight Against Cancer
By: Richard G. Hamermesh and Kathryn E. Giusti
- November 12, 2018
- Article
Precision Medicine Has Transformed Cancer Treatment. Here's How to Move It Beyond Oncology
By: Richard G. Hamermesh and Kathy Giusti
- October 4, 2018
- Article
Precision Medicine Needs a Business Mindset in Order to Flourish
By: Richard G. Hamermesh and Kathryn E. Giusti
- May 2018
- Case
The Multiple Myeloma Research Foundation's Answer Fund
By: Richard G. Hamermesh and Matthew G. Preble
Keywords:
Data Analytics;
Customer Focus and Relationships;
Customer Relationship Management;
Cost vs Benefits;
Investment Return;
Health Care and Treatment;
Innovation Leadership;
Intellectual Property;
Knowledge Sharing;
Knowledge Dissemination;
Leadership;
Leading Change;
Resource Allocation;
Goals and Objectives;
Marketing Communications;
Performance;
Programs;
Projects;
Business and Community Relations;
Business and Stakeholder Relations;
Networks;
Partners and Partnerships;
Research and Development;
Genetics;
Behavior;
Motivation and Incentives;
Social and Collaborative Networks;
Nonprofit Organizations;
Strategy;
Health Industry;
Pharmaceutical Industry;
Biotechnology Industry;
United States
- Article
Master Protocols in Oncology: A Review of the Landscape
By: Bradley Smith, Kathy Giusti, Richard G. Hamermesh and Dixie-Lee Esseltine
- April 2018
- Case
Hawk Electronics, Inc.
By: Richard G. Hamermesh and John J. Lafkas
Hawk Electronics ("Hawk") presents the problems that a company can encounter when its divisions have distinct strategies, especially when one division has been favored at another's expense. It also highlights how such problems can reflect cognitive biases, which...
View Details
- April 2018
- Teaching Note
Hawk Electronics, Inc. (Brief Case)
By: Richard G. Hamermesh and John J. Lafkas
Teaching Note for HBS Brief Case 918-521.
View Details